|
| |
| | Encyclopedia: Monoamine oxidase inhibitor |
 | | The incidence of side effects was lower than that for placebo in all other categories than skin irritation at the application site (comparable to nicotine patches, about 1 in 3). | | | Both kinds of intestinal MAO-inhbition can cause hyperpyrexia if levodopa-containing foods are consumed. | | | People who viewed "Monoamine oxidase inhibitor" also viewed: |
|
http://www.nationmaster.com/encyclopedia/Monoamine-oxidase-inhibitor
(1411 words)
|
|
| |
| | Schizophrenia, Monoamine Oxidase Activity, and Cigarette Smoking |
| | Recent studies have demonstrated that smoking is associated with reduced monoamine oxidase A and B activity (Oreland et al. | | | Despite a review of twenty-six studies convincingly demonstrating a reduction in MAO activity in platelets of chronic schizophrenic patients (Wyatt et al. | | | This study compared monamine oxidase activity level in a matched group of patients with schizophrenia who smoked with a group who did not. |
|
http://www.nature.com/cgi-taf/dynapage.taf?file=/npp/journal/v20/n4/full/1395302a.html
(1466 words)
|
|
| |
| | 20th WCP: The Monoamine Hypothesis, Placebos and Problems of Theory Construction in Psychology, Medicine, and Psychiatry |
| | So, too, with the vacuousness of explanations involving the body's "recuperative powers." These five criticisms are closely intertwined in their ramifications for scientific methodology and theory construction, such as in the monoamine hypothesis, which forms the basis of the theory of clinical depression. | | | I approach this question through an in-depth analysis of a typical experiment for clinical depression involving the monoamine hypothesis, drug action, and placebos. | | | I begin in section 2 by discussing Grünbaum's detailed analysis of what a placebo is. I then use his idea of a generic intentional Placebo and discuss one of many similar experiments concerning the phenomenon of clinical depression, experiments that use the monoamine hypothesis and the notion of a generic intentional placebo. |
|
http://www.bu.edu/wcp/Papers/Scie/ScieTang.htm
(3137 words)
|
|
| |
| | Increased Monoamine Concentration in the Brain and Blood of Fetal Thalidomide- and Valproic Acid-Exposed Rat: Putative ... |
| | Increased Monoamine Concentration in the Brain and Blood of Fetal Thalidomide- and Valproic Acid-Exposed Rat: Putative Animal Models for Autism -- NARITA et al. | | | Increased Monoamine Concentration in the Brain and Blood of Fetal Thalidomide- and Valproic Acid–Exposed Rat: Putative Animal Models for Autism | | | the brain and blood monoamine concentration when given on E9 shed light on the pathogenesis of autism from the point of view |
|
http://www.pedresearch.org/cgi/content/full/52/4/576
(2283 words)
|
|
| |
| | Monoamine Oxidase |
| | Alterations in the MAO-A gene result in marked changes in monoamine metabolism and are associated with variable cognitive deficits and behavioral changes in both humans and transgenic mice. | | | One interesting case is the association between violent criminal behavior and monoamine oxidase (MAO) activity in the brain. | | | Monoamine oxidase A degrades the neurotransmitters norepinephrine and dopamine by converting the amine group into aldehyde group. |
|
http://www.science.siu.edu/microbiology/micr302/MAO.html
(403 words)
|
|
| |
| | Monoamine Oxidase Inhibitors - Foods to avoid |
| | If a sufficient amount of pressor amines are released, a patient may experience a severe occipital or temporal headache, diaphoresis, mydriasis, nuchal rigidity, palpitations, and the elevation of both diastolic and systolic blood pressure may ensue (Anon, 1989; Da Prada et al, 1988; Brown and Bryant, 1988). | | | Q. Please review the dietary restrictions that should be observed when a patient is receiving monoamine oxidase inhibitor (MAOI) therapy? | | | Dietary restrictions are required for individuals receiving monoamine oxidase inhibitor therapy to prevent a hypertensive crisis and other side effects. |
|
http://www.biopark.org/maoi-1.html
(1671 words)
|
|
| |
| | Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. |
| | BACKGROUND: Among antidepressant augmentation strategies, the addition of a stimulant to a monoamine oxidase inhibitor (MAOI) has received little attention in the literature in recent years because of the diminished clinical use of the latter and concerns of precipitating a hypertensive crisis or other serious complication. | | | Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. |
|
http://counsellingresource.com/medications-research/2005/03/02/combining-stimulants-with-monoamine-oxidase-inhibitors-a-review-of-uses-and-one-possible-additional-indication
(523 words)
|
|
| |
| | British Journal of Pharmacology - Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in ... |
| | BERRY, M.D.,, SCARR, E.,, ZHU, M.Y.,, PATERSON, I.A. and, JUORIO, A.V. (1994) The effects of administration of monoamine oxidase-B inhibitors on rat striatal neuron responses to dopamine.. | | | KATO, T.,, DONG, B.,, ISHII, K. and, KINEMUCHI, H. (1986) Brain dialysis: In vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.. | | | Administration of the selective monoamine oxidase type B (MAO-B) inhibitor drug, deprenyl (selegiline), to human parkinsonian patients causes a symptomatic antiparkinsonian response, indicative of a dopaminergic effect in the striatum (Myllyla et al., 1992; Olanow et al., 1996). |
|
http://www.nature.com/bjp/journal/v130/n8/full/0703493a.html
(4478 words)
|
|
| |
| | Monoamine Oxidase: Basic and Clinical Aspects: Contents |
| | Reversible monoamine oxidase inhibitors: from laboratory to clinic | | | Hepatotoxicity of monoamine oxidase inhibitors in isolated and primary cultured hepatocytes of rat | | | Newer approaches to the study of monoamine oxidase inhibition |
|
http://www.vsppub.com/books/lifes/cbk-MonOxiBasCliAsp.html
(163 words)
|
|
| |
| | Omniseek: /Health /Pharmacy /Drugs and Medications /Types /Monoamine Oxidase Inhibitors (MAOIs) |
| | DEFINITION OF THERAPEUTIC MASSAGE - The scientific art and system of the assessment of and the manual application to the superficial soft tissue of skin, muscles, tendons, ligaments, fascia,... | | | DEFINITION OF THERAPEUTIC MASSAGE - The scientific art and system of the assessment of and the manual application to the superficial soft tissue of skin, muscles, tendons, ligaments,... | | | Omniseek: /Health /Pharmacy /Drugs and Medications /Types /Monoamine Oxidase Inhibitors (MAOIs) |
|
http://www.omniseek.com/srch/{87256}
(207 words)
|
|
| |
| | MAO and TSH |
| | The present work was addressed to study a possible relationship between monoamine oxidase (MAO) and the thyroid iodide transport mechanism. | | | Monoamine oxidase (MAO) seems depressed in many cases of hyperthyroidism and at an excess in manic depression. | | | I've run across some studies indicating that monoamine oxidase inhibitors (MAOIs) which are used as antidepressant drugs can suppress TSH levels in a fairly high percentage of patients. |
|
http://www.ithyroid.com/mao_and_tsh.htm
(1073 words)
|
|
| |
| | Monoamine Oxidase: Basic and Clinical Aspects |
| | During the past three decades the enzymological properties of MAO have been studied extensively. | | | Monoamine oxidase (MAO), a mitochondrial enzyme which metabolizes monoamines in both the central nervous system and peripheral tissues, plays an important role in the regulation of neuronal activities by controlling the concentrations of monoamines. |
|
http://www.vsppub.com/books/lifes/bk-MonOxiBasCliAsp.html
(238 words)
|
|
| |
| | antidepressant, MAOI, monoamine oxidase inhibitor, MAOI as an antidepressant, tyramine interaction, side effects, ... |
| | antidepressant, MAOI, monoamine oxidase inhibitor, MAOI as an antidepressant, tyramine interaction, side effects, applications, benefits of MAOI, Depression, Alternative therapies, mind-body medicine, integrative therapies | | | Monoamine oxidase is an enzyme that is found in many parts of the body. | | | So MAO inhibitors, by limiting the activity of monoamine oxidase, block the breakdown of those neurotransmitters. |
|
http://holisticonline.com/Remedies/Depression/dep_antidepressant-MAOI.htm
(325 words)
|
|
| |
| | MedlinePlus Drug Information: Antidepressants, Monoamine Oxidase (MAO) Inhibitor (Systemic ) |
| | MedlinePlus Drug Information: Antidepressants, Monoamine Oxidase (MAO) Inhibitor (Systemic) | | | Monoamine oxidase (MAO) inhibitors are used to relieve certain types of mental depression. | | | Although these medicines are very effective for certain patients, they may also cause some unwanted reactions if not taken in the right way. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202054.html
(2521 words)
|
|
| |
| | MSN Encarta - Dictionary - monoamine oxidase inhibitor |
| | antidepressant drug: a drug that blocks the breakdown of monoamines by monoamine oxidase in the brain. | | | MSN Encarta - Dictionary - monoamine oxidase inhibitor | | | Click here to search all of MSN Encarta |
|
http://encarta.msn.com/dictionary_1861693782/monoamine_oxidase_inhibitor.html
(64 words)
|
|
| |
| | Blue Genes and the Monoamine Hypothesis of Depression/Brainstorms February 2000 |
| | The anatomy of mood disorders: review of structural neuroimaging studies. | | | Currently, the evolving monoamine hypothesis considers the possibility that depression may be linked to a deficiency in signal transduction from the monoamine neurotransmitter to its postsynaptic neuron in the presence of normal amounts of neurotransmitter and receptor. | | | lthough the monoamine hypothesis of depression proposes that depression is due to a deficiency in monoaminergic neurotransmission, no deficiencies in the levels or receptors for serotonin, dopamine, and/or norepinephrine have been consistently reported. |
|
http://www.psychiatrist.com/pcc/brainstorm/br6102.htm
(691 words)
|
|
| |
| | Monoamine Oxidase Inhibitors (MAOIs) |
| | These new drugs affected the same neurotransmitters (serotonin and norepinephrine) that the tricyclics did, but they also affected dopamine. | | | Unfortunately, monoamine oxidase doesn't just destroy those neurotransmitters; it's also responsible for mopping up another amine called tyramine, a molecule that affects blood pressure. | | | And since depression is associated with low levels of these monoamines, it's not surprising that increasing the monoamines ease depressive symptoms. |
|
http://my.webmd.com/content/article/87/99355.htm
(1148 words)
|
|
| |
| | [No title] |
| | While Tatton’s experiment showed that deprenyl could save neurons, another study showed it to be ineffective against human melanoma cells (Malorni, W., et al. | | | This has been demonstrated in a number of experiments. | | | This experiment compared the ability of deprenyl to the ability of a few monoamine oxidase A inhibitors on protecting a cell against apoptosis due to starvation. |
|
http://sulcus.berkeley.edu/mcb/165_001/papers/manuscripts/_400.html
(3074 words)
|
|
| |
| | eMedicine - Toxicity, Monoamine Oxidase Inhibitor : Article by Steven Marcus, MD |
| | For this reason, pharmaceutical research has produced drugs that can either block the reuptake of neurotransmitters (eg, cyclic antidepressants, newer selective serotonin reuptake inhibitors) or interfere with the breakdown of the monoamines within the synaptic cleft (monoamine oxidase inhibitors [MAOIs]). | | | It is hypothesized that clinical depression is related to decreases in concentration of the neurotransmitters. | | | Circulating monoamines such as epinephrine, norepinephrine, and dopamine, are inactivated when they pass through a liver rich in MAO-A. MAO-B, on the other hand, is found primarily in the brain and in platelets. |
|
http://www.emedicine.com/EMERG/topic318.htm
(2427 words)
|
|
| |
| | Monoamine oxidase inhibitors (MAOIs) and borderline personality disorder, Eastern Carolina |
| | Monoamine oxidase inhibitors (MAOIs) and borderline personality disorder | | | A few monoamine oxidase inhibitors (MAOIs) that may be prescribed to reduce symptoms associated with borderline personality disorder include isocarboxazid (Marplan), phenelzine sulfate (Nardil), and tranylcypromine sulfate (Parnate). | | | When these brain chemicals are in proper balance, symptoms associated with borderline personality disorder (such as anger, irritability, and impulsive behavior) are relieved. |
|
http://www.uhseast.com/134043.cfm
(465 words)
|
|
| |
| | Monoamine oxidase - Wikipedia, the free encyclopedia |
| | Monoamine oxidase inhibitors are one of the major classes of drug prescribed for the treatment of depression. | | | For example, unusually high or low levels of MAOs in the body have been associated with depression, substance abuse, criminality, attention deficit disorder, and social phobias. | | | MAO-A is particularly important in the digestion of monoamines ingested in food. |
|
http://en.wikipedia.org/wiki/Monoamine_oxidase
(298 words)
|
|
| |
| | Lycaeum > Leda > MAOIs -- Monoamine Oxidase Inhibitors |
| | MAOIs are antidepressants which are effictatious in the treatment of atypical depression (vegitative symptoms, anxiety, initial insomnia, etc), panic disorder, anxiety and (recently discovered) borderline personality disorder. | | | Use: This diet is used to assist counseling of persons receiving monoamine oxidase (MAO)inhibitors for treatment of anxiety and depression. | | | Low-Tyramine Diet Purpose: To prevent the onset of adverse reactions such as severe headaches, tachycardia, and hypertensive attacks by persons receiving monoamine oxidase (MAO) therapy and consuming foods high in tyramine content. |
|
http://leda.lycaeum.org/Documents/MAOIs_--_Monoamine_Oxidase_Inhibitors.13334.shtml
(565 words)
|
|
| |
| | Scientists determine the structure of human Monoamine Oxidase B (MAO B) |
| | Monoamine oxidases (MAO B and MAO A) are well-known targets for antidepressant drugs and for drugs used to treat neurological disorders and diseases of aging, such as Parkinson’s disease and Alzheimers disease. | | | Scientists determine the structure of human Monoamine Oxidase B (MAO B) Scientists from Emory University School of Medicine and the University of Pavia, Italy, have determined for the first time the three-dimensional structure of monoamine oxidase B (MAO B) — an enzyme important in several major disease processes; particularly age-related neurological disorders. | | | Understanding the detailed structure of the enzyme should provide a framework for designing new neuroprotective drugs. |
|
http://www.eurekalert.org/pub_releases/2001-11/euhs-sdt_1112101.php
(639 words)
|
|
| |
| | Gale Encyclopedia of Medicine: Monoamine oxidase inhibitors |
| | Monoamine oxidase inhibitors (MAO inhibitors) are medicines that relieve certain types of mental depression. | | | MAO inhibitors are a type of antidepressant and are used to treat mental depression. | | | Save a personal copy of this article and quickly find it again with Furl.net. |
|
http://www.findarticles.com/p/articles/mi_g2601/is_0009/ai_2601000906
(977 words)
|
|
| |
| | Monoamine oxidase (MAO) - Gerard J. Kleywegt |
| | Knowledge of this structure will facilitate the design of new, potent, and selective MAO inhibitors, which may eventually lead to new and effective drugs for the treatment of depression and possibly of other disorders. | | | This drug also has a weak effect in the treatment of depression, and some beneficial action has been reported in patients with mild Alzheimer-type dementia, narcolepsy, attention-deficit disorders, and Lafora-type epilepsy. | | | MAO is involved in the biodegradation of aromatic monoamines, including classical neurotransmitters such as serotonin, adrenalin, histamine, and dopamine, and appears to play a central role in several psychiatric and neurological disorders. |
|
http://alpha2.bmc.uu.se/gerard/mao.html
(637 words)
|
|
| |
| | Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage. |
| | These results are interpreted with respect to the use of monoamine oxidase inhibitors in the treatment of Parkinson's disease. | | | The administration of high doses of methamphetamine causes long lasting damage to central dopaminergic and serotonergic neurons through a mechanism known to involve presynaptic, cytoplasmic stores of those transmitters and thought to be dependent upon a free radical reaction. | | | Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage. |
|
http://www.arclab.org/medlineupdates/abstract_1905457.html
(183 words)
|
|
| |
| | Specific Genetic Deficiencies of the A and B Isoenzymes of Monoamine Oxidase Are Characterized by Distinct ... |
| | Specific Genetic Deficiencies of the A and B Isoenzymes of Monoamine Oxidase Are Characterized by Distinct Neurochemical and Clinical Phenotypes | | | Specific Genetic Deficiencies of the A and B Isoenzymes of Monoamine Oxidase Are Characterized by Distinct Neurochemical and Clinical Phenotypes -- Lenders et al. | | | Siciliano, G.J. Darlington, and R.M. Denney (1986) Assignment of genes for human monoamine oxidases A and B to the X-chromosome. |
|
http://www.jci.org/cgi/content/full/97/4/1010
(5178 words)
|
|
| |
| | Expanding the horizons of depression: beyond the monoamine hypothesis |
| | The monoamine hypothesis cannot conclusively link the acute biochemical action of antidepressants on monoamine levels with their delayed clinical effect of 10-14 days, nor can it explain the mode of action of antidepressants that are effective despite being very weak inhibitors of monoaminergic transmission (e.g. | | | The monoamine hypothesis has dominated our understanding of depression and of pharmacological approaches to its management and it has produced several generations of antidepressant agents, ranging from the monoamine oxidase inhibitors (MAOIs), through tricyclics (TCAs) and selective serotonin reuptake inhibitors (SSRIs), to the recently introduced selective noradrenaline reuptake inhibitor (NARI), reboxetine. | | | Compared with other fields of medicine, there has been a lack of progress in understanding the pathophysiology of depression and producing truly novel antidepressant agents. |
|
http://www.ei-resource.org/Articles/mental-art01.asp
(307 words)
|
|
| |
| | Monoamine - Wikipedia, the free encyclopedia |
| | Several mood disorders are explained as due to either an excess or deficiency of monoamines. | | | In biochemistry, monoamines are a group of organic compounds containing only one amino group. | | | This page was last modified 08:29, 3 February 2005. |
|
http://en.wikipedia.org/wiki/Monoamine
(78 words)
|
|
| |
| | Monoamine oxidase - Wikipedia, the free encyclopedia |
| | A strong association between lack of MAO activity and criminality was previously reported in another study of a family in which a null-activity MAOA gene was being transmitted (as opposed to the more common, merely low-activity allele, in Caspi’s study). | | | It is interesting to observe that one class of anti-depressant drugs acts by inhibiting monoamine oxidase. | | | These enzymes occur in nature in two similar but distinct forms, MAO A and MAO B, which are coded for by separate genes. |
|
http://www.phatnav.com/wiki/index.php?title=Monoamine_oxidase
(856 words)
|
|
| |
| | BehaveNet® Clinical Capsule™: monoamine oxidase inhibitor (MAOI) |
| | Sharing a common biochemical action they are notorious for dangerous interactions with chemicals found in certain foods as well as with a variety of prescription and non-prescription drugs. | | | Kennedy, Sidney H., M.D. (Editor) Clinical Advances in Monoamine Oxidase Inhibitor Therapies (Progress in Psychiatry, No 43)(8474) Hardcover 1994 -"An internationally renowned group of experts present new findings on the relationships among monoamine oxidase, its inhibition, and psychiatric disorders, as well as a detailed explanation of selectivity and reversibility of enzyme inhibition." | | | Stephen Stahl's Clinical Pearls* (Consult your physician before making any change in your treatment.) |
|
http://www.behavenet.com/capsules/treatments/drugs/maoi.htm
(206 words)
|
|
| |
| | Monoamine-oxidase inhibitors (Group PIM G025) |
| | As for non selective MAOIs, the serotonergic effects may be enhanced by combination with tricyclic antidepressants, other MAOIs, selective serotonin reuptake inhibitors (SSRIs), or lithium, causing a life-threatening serotonin syndrome. | | | Short acting selective and reversible monoamine oxidase type A inhibitors are generally well tolerated in overdose when taken alone, and the clinical course is usually benign (Iwersen & Schmoldt, 1996). | | | Although dantrolene has been used successfully, its role in the management of the serotonin syndrome has yet to be evaluated. |
|
http://www.inchem.org/documents/pims/pharm/pimg025.htm
(2258 words)
|
|
| |
| | Monoamine oxidase inhibitors (MAOIs) |
| | Researchers believe MAOIs relieve depression by preventing the enzyme monoamine oxidase from metabolizing the neurotransmitters norepinephrine (nor-ep-ih-NEF-rin), serotonin (ser-oh-TOE-nin) and dopamine (DOE-puh-mene) in the brain. | | | As a result, these levels remain high in the brain, boosting mood. | | | Monoamine oxidase inhibitors (MAOIs) were the first type of antidepressant in use, dating back to the 1950s. |
|
http://robots.cnn.com/HEALTH/library/MH/00072.html
(411 words)
|
|
| |
| | Research project - Monoamine oxidase (MAO) |
| | Monoamine oxidase (MAO) is important in the metabolism of aromatic amines, including neurotransmitters such as serotonin, adrenaline, histamine and dopamine. | | | The first modern antidepressants were irreversible and unspecific inhibitors of MAO, but due to their adverse side effects they fell into disuse. | | | An older page about MAO can be found here. |
|
http://alpha2.bmc.uu.se/gerard/research_mao.html
(341 words)
|
|
| |
| | Amazon.ca: Books: Inhibitors of Monoamine Oxidase B. |
| | Look for books like Inhibitors of Monoamine Oxidase B. by subject: | | | Use Your Account to view or change your orders | | | Amazon.ca: Books: Inhibitors of Monoamine Oxidase B. Search |
|
http://www.amazon.ca/exec/obidos/ASIN/3764327820
(94 words)
|
|
| |
| | Monoamine oxidase inhibitors |
| | Genetic Deficiencies of Monoamine Oxidase by Graeme Eisenhofer. | | | MAO-Inhibitors, a discussion: From a mailing list devoted to visionary plants comes this discussion of the differences between MAO-A and MAO-B, the results of their selective inhibitions (especially where it concerns the "Cheese Syndrome"), and the possible role of MAO-Inhibitors in potentiating psychedelic drugs. | | | Eros and the Pineal: The Layman's guide to cerebral solitare by Albert Most. |
|
http://nepenthes.lycaeum.org/Drugs/Misc/maoi.html
(111 words)
|
|
| |
| | Monoamine Oxidase |
| | This is "monoamine oxidase" (MAO), an enzyme that breaks down serotonin (serotonin is a monoamine, remember). | | | After your reuptake pumps remove the serotonin, MAO breaks most of it down. | | | This is true, but notice the hammers inside the axon. |
|
http://www.dancesafe.org/slideshow/slide14.html
(182 words)
|
|
| |
| | Monoamine products |
| | The JEFFAMINE® monoamines are designated with an M. The M is representative of the fact that they are Monoamines. | | | The number designation after the letter M represents the approximate molecular weight. |
|
http://www.huntsman.com/performance_products/index.cfm?PageID=2137
(99 words)
|
|
|
